Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Business studies finance ratios
Strengths and weaknesses of financial ratios
Business studies finance ratios
Don’t take our word for it - see why 10 million students trust us with their essay needs.
This ratio is the most accurate since it entails the liquid funds and compared with the short term obligations of the company. The higher the quick ratio, the stronger is the company’s level of liquidity. For ACADIA Pharmaceuticals Inc., the cash ratio for 2012 was far too high (9.734196). For 2011 and 2010, the ratio was slightly above the recommended level (1.117437 and 1.149354 respectively). The company’s strong liquidity shows that the company is able to operate at no risk of liquidation in the short run. Weak liquidity is a forerunner to bankruptcy. Financing operations is a problem when the company is weak in its liquidity. The company should continue to promote sales to ensure more liquid assets are available in the company and this …show more content…
ACADIA Pharmaceuticals Inc. made loss in 2011 and 2012. The margin was negative because the costs exceeded the income for the two periods. However, the loss was higher in 2011 than 2012. In 2010, the company had a positive net profit margin. Making net loss means that the shareholders will not be compensated in those years. The company improved and was more efficient in controlling the expenses at a given level of interest rate in 2012 than in 2011. This is an encouraging trend to the shareholders because they are able to get more profits in the future should the trend continue. The expenses should as lower than the gross profit as possible so that it may result to high net profit. To improve on the net profit margin, the company should try to minimize the expenses that are incurred in running the …show more content…
ACADIA Pharmaceuticals Inc. recorded losses in 2012 and 2011 and investment in the total assets did not yield profit. However, there was improvement between 2011 and 2012 from -71% to – 19%. This shows that there was more efficiency in utilizing total assets in 2012 than in 2011. In 2010, there was a positive Return on investment of 39% meaning that the company made 39% of net profit from utilization of total assets. The trend is illustrated below: 3.2.4. Return on Equity (ROE). According to Eisen (2007), this ratio shows how much of the profit was made from utilization of the equity capital. For ACADIA Pharmaceuticals Inc., investment of Equity capital yielded negative results in 2012 (-25%) and 2011 (-97%). However, the results of 2010 yielded positive results with ROE of 51%. There was a great improvement from ROE of -97% in 2011 to ROE of -25% in 2012. This is an improvement between the two years. Increase in ROE means that the company is performing better and Equity invested on the owners of the company is well invested in productive projects. The figure above shows the trend of the ROE for the three years. If the trend continues beyong 2012, the company is likely to make higher returns in the future and earn positive results for equity
This requirement makes it important to look through a majority of the return ratios, which include return on sales, return on assets, and return on equity. Additionally, investors are also interested in the ratios related to the company’s earnings, such as earnings per share (EPS) and PE ratio. Looking at return on sales, we can see that Wendy’s has a 7.27% return on sales and Bob Evans has a 1.23%, which demonstrates Wendy’s has a higher profit margin. Moreover, Wendys’ return on assets is 2.85% and Bob Evans is 1.58%. Also, Wendy’s and Bob Evan 's have return on equity ratios of 6.66% and 4.30%, respectively. All of these return ratios show that Wendy’s has a better handle on turning working capital into revenue. On the other hand, although Wendy’s return ratios are higher than Bob Evans, Bob Evans has a better performance on earnings per share and PE ratio. This is due to Bob Evans having less common stock share outstanding, which makes their earnings per share and PE ratio higher than Wendy’s. Due to the EPS being higher for Bob Evans, we would recommend that investors look towards Bob
Med-Pharmex Incorporated is known nationally and abroad as a pharmaceutical manufacturer of animal-related products. Before gaining fame worldwide, the business began its journey to success as a small lab in 1983, which slowly grew over time. Since then, the company maintains its main goal, and that is to produce drugs that promote the health of companion animals, such as dogs, cats, and horses, as well as food-producing animals, such as pork and chickens. To ensure legal responsibility, the company’s manufacturing process is examined by the United States Food and Drug Administration (FDA). Med-Pharmex works closely with veterinary clinics who purchase their life-saving drugs and represent them in the market. Despite manufacturing drugs, the
The improvement in the current ratio during the period demonstrates an increase in the company’s ability to meet its current obligations. The ratio of 1.4, up from 1.2, means that Walgreen can cover its short term obligation by 140%. The quick ratio indicates the company’s ability to cover its current obligations from cash, cash equivalents, and accounts receivable. It is a good indication of the reliance of the business on its conversion of inventory to pay current obligations. In the case of Walgreen, the ratio improved from 0.4 to 0.7. However, this is still less than 1 time, meaning that it only has 70% of its current obligations covered by assets that are easily converted to cash. Thus, indicating a heavy reliance on
This company has been performing well for many years and this this because of their good business model. Everything that was noticed on the income statement was the good performance of company. Their dividends have increased over time; this was due to increased profits. The earnings growth projections for the next four years have increased five percent.
Background: Merck & Co. is an American pharmaceutical company and one of the largest pharmaceutical companies in the world. In 1971 the United States approved the use of an MMR vaccine made by Merck, containing the Jeryl Lynn strain of mumps vaccine. In 1978 Merck introduced the MMR II, using a different strain of the rubella vaccine. In 1997 the FDA required Merck to conduct effectiveness testing of MMRII. Initially it was over 95%; to continue the license; Merck had to convince the FDA that the effectiveness stayed at a similar rate over the years.
Return on sales is decreasing and is below the industry average, but the goods news is that sales and profits have been increasing each year. However, costs of goods are increasing and more inventory is left over each year causing the return on sales to decrease. For 1995, it was 1.7% which is less than the average of 2.44% but is a lot higher than the bottom 25% of companies as seen in exhibit 3, which actually have negative sales return of 0.7%. Return on equity is increasing each year and at a higher rate than industry average. In 1995, it was 20.7%, greater than the average of 18.25% and close to the highest companies in exhibit 3, of 22.1% showing that the return in investment in the company is increasing, which is good for the owner.
Return on equity (ROE) measures profitability from the stockholders perspective. The ROE is a calculation of the return earned on the common stockholders' investment in the firm. Generally, the higher this return, the better off the stockholders are. Harley Davidson's return on equity was 24.92% for 2001, 24.74% for 2000. They have sustained consistent, positive, returns for their shareholders for the past two years.
The Dupont analysis shows that every dollar of assets generates 2.44 in sales which is great considering it was already good in 2014 and 2015 and keeps improving each year, the equity multiplier is 2.516 indicating that ROE is generated through efficient use of equity and leverage of 60% that can be increased slightly to surge ROE.
Notably, its share price has dropped 43% just in the last year, after the publication of the year losses of €6.8 billion (remarkably €2.8 billion more than the losses of 2008) . The ROE for the bank passed from 7.89% in 2010 to minus -9.02% at the end of 2015. Based on the figures in the latest interim report in July 2016 the ratio decreased further to -11.52% in June . Considering this trend, we need to take into account also that in recent years, the ROE was consistently below the cost of capital, eroding value. A company can increase its ROE in 2 ways: increasing the numerator - raising your net income - or decreasing the denominator – the equity capital. Banks represent generally a capital-intense business, and the introduction of tighter regulations is posing difficulties to the banks that aim to reduce their equity capital. It appears clear that the only way to achieve a better ROE is to attain a high financial leverage . The pre-financial crisis leverage level was impressive (71.73%), and today is 27.11%, above the standard of its direct competitors .The return on assets has also decreased in the last six years and has reached a negative level of -0.46%
The Dupont analysis includes the asset turnover ratio, the profit margin percantage, return on shareholder’s equity percentage, return on assets, and the equity multiplier (Spiceland, Sepe, and Nelson 258-264). The asset turnover ratio is the amount of revenue received for every one dollar of assets, it reveals how efficiently the company is distributing assets. Apple’s asset turnover ratio is 60.43 which means for every one dollar Apple has in assets, they receive approximately sixty cents (Apple Inc). Microsoft’s asset turnover ratio is 13.17 so for every dollar they only receive about thirteen cents (Microsoft Inc). Apple is doing significantly better in this category. The profit margin is just how much of a company’s sales they keep as a profit. Apple’s profit margin is 21.67% while Microsoft has a 28% profit margin so Microsoft is accumulating more profit off each sale but their sales are lower. The return on shar...
In regards to the corporation’s balance sheet, it is necessary to place an importance on liquidity ratios to demonstrate the company’s ability to pay its short term obligations such as accounts payable and notes that have a duration of less than one year. These commonly used liquidity ratios include the current ratio, quick ratio, and cash ratio. All three ratios are used to measure the liquidity of a company or business. The current ratio is used to indicate a business’s ability to meet maturing obligations. The quick ratio is used to indicate the company’s ability to pay off debt. Finally the cash ratio is used to measure the amount of capital as well short term counterparts a business has over its current liabilities.
With the increased cost of manufacturing, pharmaceutical companies have been divesting in their smaller or less profit making operations and focus on large segments. Many Pharmaceutical companies sold their manufacturing sites to contract manufacturing organizations. The dynamics of interfacing with contract manufacturing organization added intricacy in pharmaceutical supply chain network of pharmaceutical companies.
The vertical analysis shows that the percentage of total current assets to total assets increased from 50% to 52%. This means that IQ has not made major investments in the business during 2005.
What is a pharmaceutical company’s main objective? You might think it is to cure people of illnesses or even make people healthier. However new research and public information shows that while they work in health care health is not what they are starting distribute. “A pharmaceutical company, or drug company, is a commercial business licensed to research, develop, market and/or distribute drugs, most commonly in the context of healthcare. They can deal in generic and/or brand medications.” Although they are a vital part of any economy and health field there are many problems with in the medical industry such as (a) the focus of money, (b) drug abuse, (c) over consumption and (d) severe side effects. Pharmaceutical companies should be better managed and regulated in the United States. There is an unethical balance in how the industry is controlled. They are in it for profit not treatment.
The analysis of these ratios shows how Ford stands as a company for the past five years. Return on equity (ROE) reveals how much profit a company earned in comparison to the total amount of shareholder equity on the balance sheet. For long-term investing with great rewards, companies that have high return on equity ratios can provide the biggest payoffs. This ratio also tells investors how effectively their capital is being reinvested, so it is a good gauge of management's money handling skills. Ford is showing a considerable turn around in this area this past year, which could easily be due to changes in management. They are also reasonably following the industry in this area.